US Bancorp’s Bioverativ Inc. Common Stock BIVV Stock Holding History

US Bancorp’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,348	Closed	-$396K	–	3784
2017 Q4	$396K	Sell	7,348 -4,350	-37%	-$238K	﹤0.01%	1545
2017 Q3	$667K	Sell	11,698 -5,417	-32%	-$317K	﹤0.01%	1278
2017 Q2	$1.03M	Sell	17,115 -20,396	-54%	-$1.16M	﹤0.01%	1042
2017 Q1	$2.04M	Buy	+37,511	New	+$1.85M	0.01%	770

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

US Bancorp's BIVV Position: Q1 2018 in Review

US Bancorp sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,348 shares — an estimated $396K sold.

US Bancorp first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.04M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

US Bancorp reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
US Bancorp sold 7,348 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $396K.
US Bancorp first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
US Bancorp's Bioverativ Inc. Common Stock position peaked at $2.04M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on US Bancorp's 13F filing for Q1 2018, filed 8 May 2018.